Frontiers in Genetics | Cancer Genetics and Oncogenomics

Original Research

Published on 25 Oct 2022

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis

in Cancer Genetics and Oncogenomics

Maria Palmieri
Elisabetta Zulato
Sissel Gyrid Freim Wahl
Nicolas Guibert
Elisa Frullanti

Frontiers in Genetics

doi 10.3389/fgene.2022.1015161

3,413 views
9 citations

Correction

Published on 25 Oct 2022

Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Fang Tong
Lifa Xu
Sheng Xu
Mingming Zhang

Frontiers in Genetics

doi 10.3389/fgene.2022.1050296

1,495 views

Original Research

Published on 24 Oct 2022

A novel m7G methylation–related signature associated with chromosome homeostasis in patients with lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Xiaoying Tao
Run Huang
Rujun Xu
Shuang Zheng
Juanqing Yue

Frontiers in Genetics

doi 10.3389/fgene.2022.998258

2,802 views
4 citations

Original Research

Published on 24 Oct 2022

Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response

in Cancer Genetics and Oncogenomics

Jin Cao
Yichen Liang
J. Juan Gu
Yuxiang Huang
Buhai Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.991162

3,763 views
9 citations

Original Research

Published on 24 Oct 2022

Identification of biomarkers for hepatocellular carcinoma based on single cell sequencing and machine learning algorithms

in Cancer Genetics and Oncogenomics

Weimin Li
Jixing Liu
Wenjuan Zhu
Xiaoxin Jin
Zhi Yang
Wenzhe Gao
Jichun Sun
Hongwei Zhu

Frontiers in Genetics

doi 10.3389/fgene.2022.873218

4,766 views
6 citations

Original Research

Published on 24 Oct 2022

High expression of MARVELD3 as a potential prognostic biomarker for oral squamous cell carcinoma

in Cancer Genetics and Oncogenomics

Ke Huang
Yucheng Meng
Jiyuan Lu
Lingdan Xu
Shiqi Wang
Huihui Wang
Zhaoqing Xu

Frontiers in Genetics

doi 10.3389/fgene.2022.1050402

2,873 views
5 citations

Original Research

Published on 24 Oct 2022

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma

in Cancer Genetics and Oncogenomics

Jiasheng Zhong
Jie Liu
Zhilin Huang
Yaofeng Zheng
Jiawen Chen
Jingsen Ji
Taoliang Chen
Yiquan Ke

Frontiers in Genetics

doi 10.3389/fgene.2022.1026192

3,417 views
1 citation

Original Research

Published on 24 Oct 2022

Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis

in Cancer Genetics and Oncogenomics

Lin-Kai Yang
Can-Xiang Lin
Sheng-Hong Li
Jia-Ji Liang
Li-Ling Xiao
Guang-Hui Xie
Hong-Wei Liu
Xuan Liao

Frontiers in Genetics

doi 10.3389/fgene.2022.1036402

4,925 views
7 citations

Original Research

Published on 21 Oct 2022

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma

in Cancer Genetics and Oncogenomics

Yifan Xu
Chao Wang
Shifang Li
Han Zhou
Yugong Feng

Frontiers in Genetics

doi 10.3389/fgene.2022.975419

4,687 views
9 citations

Original Research

Published on 21 Oct 2022

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma

in Cancer Genetics and Oncogenomics

Ming Sun
Shanshan Qi
Min Wu
Wei Xia
Hao Xiong

Frontiers in Genetics

doi 10.3389/fgene.2022.909556

3,820 views
5 citations

Original Research

Published on 21 Oct 2022

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma

in Cancer Genetics and Oncogenomics

Fan Ye
Pingan Wu
Yaqiong Zhu
Guan Huang
Ying Tao
Zhencheng Liao
Yafeng Guan

Frontiers in Genetics

doi 10.3389/fgene.2022.989081

3,551 views
4 citations

Original Research

Published on 21 Oct 2022

A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival

in Cancer Genetics and Oncogenomics

Carlos A. Barrón-Gallardo
Mariel Garcia-Chagollán
Andres J. Morán-Mendoza
Raul Delgadillo-Cristerna
María G. Martínez-Silva
María M. Villaseñor-García
Adriana Aguilar-Lemarroy
Luis F. Jave-Suárez

Frontiers in Genetics

doi 10.3389/fgene.2022.991706

8,349 views
15 citations

Review

Published on 21 Oct 2022

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer

in Cancer Genetics and Oncogenomics

Liyuan Gao
Weizhang Shen

Frontiers in Genetics

doi 10.3389/fgene.2022.890247

11,330 views
11 citations

Original Research

Published on 21 Oct 2022

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy

in Cancer Genetics and Oncogenomics

Wei Wei
Chao Liu
Caihong Wang
Meng Wang
Wei Jiang
Yaqian Zhou
Shuqun Zhang

Frontiers in Genetics

doi 10.3389/fgene.2022.1016797

5,771 views
6 citations

Original Research

Published on 20 Oct 2022

Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation

in Cancer Genetics and Oncogenomics

Hannah G. Daniels
Breanna G. Knicely
Anna Kristin Miller
Ana Thompson
Rina Plattner
Eva M. Goellner

Frontiers in Genetics

doi 10.3389/fgene.2022.940073

4,283 views
1 citation

Original Research

Published on 20 Oct 2022

Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation

in Cancer Genetics and Oncogenomics

Xinyu Zhang
Xinyue Qin
Tiannan Yu
Kexin Wang
Yinhao Chen
Qianwei Xing

Frontiers in Genetics

doi 10.3389/fgene.2022.974726

2,670 views
7 citations

Original Research

Published on 20 Oct 2022

Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study

in Cancer Genetics and Oncogenomics

Shuai Liu
Liuyuan Zhao
Guohua Zhou

Frontiers in Genetics

doi 10.3389/fgene.2022.1016085

2,680 views
13 citations

Original Research

Published on 20 Oct 2022

Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer

in Cancer Genetics and Oncogenomics

Shengnan Gao
Xinjie Wu
Xiaoying Lou
Wei Cui

Frontiers in Genetics

doi 10.3389/fgene.2022.960567

2,992 views
3 citations

Original Research

Published on 20 Oct 2022

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy

in Cancer Genetics and Oncogenomics

Xinghe Liao
Hui Liu
Zhe Zhang
Jing Zhang
Chenyue Zhang
Weiwei Zhao

Frontiers in Genetics

doi 10.3389/fgene.2022.1010787

2,391 views
5 citations

Original Research

Published on 20 Oct 2022

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma

in Cancer Genetics and Oncogenomics

Kai Gan
Keying Zhang
Yu Li
Xiaolong Zhao
Hongji Li
Chao Xu
Shaojie Liu
Chao Zhang
Donghui Han
Weihong Wen

Frontiers in Genetics

doi 10.3389/fgene.2022.1021163

5,974 views
1 citation

Review

Published on 19 Oct 2022

Single-cell sequencing technologies in bladder cancer research: Applications and challenges

in Cancer Genetics and Oncogenomics

Tianqi Lyu
Yuanbin Lin
Kerong Wu
Zhanglei Cao
Qian Zhang
Jianping Zheng

Frontiers in Genetics

doi 10.3389/fgene.2022.1027909

9,286 views
10 citations

Original Research

Published on 18 Oct 2022

A novel prognostic model based on six methylation-driven genes predicts overall survival for patients with clear cell renal cell carcinoma

in Cancer Genetics and Oncogenomics

Hongmin Zhou
Tiancheng Xie
Yuchen Gao
Xiangcheng Zhan
Yunze Dong
Ding Liu
Yunfei Xu

Frontiers in Genetics

doi 10.3389/fgene.2022.996291

3,266 views
8 citations

Original Research

Published on 18 Oct 2022

A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values

in Cancer Genetics and Oncogenomics

Ying Liu
Gengqiu Luo
Yuanliang Yan
Jinwu Peng

Frontiers in Genetics

doi 10.3389/fgene.2022.1038174

12,376 views
25 citations

Original Research

Published on 18 Oct 2022

Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma

in Cancer Genetics and Oncogenomics

Di Zheng
Kezhou Xia
Zhun Wei
Zicheng Wei
Weichun Guo

Frontiers in Genetics

doi 10.3389/fgene.2022.944978

4,781 views
8 citations

1,177 articles

articles

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis

Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

A novel m7G methylation–related signature associated with chromosome homeostasis in patients with lung adenocarcinoma

Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response

Identification of biomarkers for hepatocellular carcinoma based on single cell sequencing and machine learning algorithms

High expression of MARVELD3 as a potential prognostic biomarker for oral squamous cell carcinoma

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma

Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma

A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy

Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation

Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation

Peripheral blood markers predict immunotherapeutic efficacy in patients with advanced non-small cell lung cancer: A multicenter study

Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma

Single-cell sequencing technologies in bladder cancer research: Applications and challenges

A novel prognostic model based on six methylation-driven genes predicts overall survival for patients with clear cell renal cell carcinoma

A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values

Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma